These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15142389)

  • 1. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation.
    Cornelius JR; Bukstein OG; Salloum IM; Kelly TM; Wood DS; Clark DB
    J Child Adolesc Psychopharmacol; 2004; 14(1):33-8. PubMed ID: 15142389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.
    Cornelius JR; Clark DB; Bukstein OG; Kelly TM; Salloum IM; Wood DS
    Addict Behav; 2005 May; 30(4):807-14. PubMed ID: 15833583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
    Cornelius JR; Bukstein OG; Birmaher B; Salloum IM; Lynch K; Pollock NK; Gershon S; Clark D
    Addict Behav; 2001; 26(5):735-9. PubMed ID: 11676382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
    Cornelius JR; Bukstein OG; Wood DS; Kirisci L; Douaihy A; Clark DB
    Addict Behav; 2009 Oct; 34(10):905-9. PubMed ID: 19321268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents.
    Cornelius JR; Douaihy A; Bukstein OG; Daley DC; Wood SD; Kelly TM; Salloum IM
    Addict Behav; 2011 Aug; 36(8):843-8. PubMed ID: 21530092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.
    Kranzler HR; Burleson JA; Korner P; Del Boca FK; Bohn MJ; Brown J; Liebowitz N
    Am J Psychiatry; 1995 Mar; 152(3):391-7. PubMed ID: 7864265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review.
    Cornelius JR; Clark DB; Bukstein OG; Birmaher B; Salloum IM; Brown SA
    Addict Behav; 2005 Oct; 30(9):1824-33. PubMed ID: 16102905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 5-year follow-up of depressed and bipolar patients with alcohol use disorder in an Irish population.
    Farren CK; Murphy P; McElroy S
    Alcohol Clin Exp Res; 2014 Apr; 38(4):1049-58. PubMed ID: 24428168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.
    Cornelius JR; Salloum IM; Ferrell R; Douaihy AB; Hayes J; Kirisci L; Horner M; Daley DC
    Int J Med Biol Front; 2012; 18(6):399-411. PubMed ID: 25328373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
    Cornelius JR; Salloum IM; Haskett RF; Daley DC; Cornelius MD; Thase ME; Perel JM
    Addict Behav; 2000; 25(2):307-10. PubMed ID: 10795957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of medical comorbidity on acute treatment in major depressive disorder.
    Iosifescu DV; Nierenberg AA; Alpert JE; Smith M; Bitran S; Dording C; Fava M
    Am J Psychiatry; 2003 Dec; 160(12):2122-7. PubMed ID: 14638581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain has a strong negative impact on the fluoxetine response in hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Clin J Pain; 2011; 27(9):805-10. PubMed ID: 21677571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study.
    Gelenberg AJ; Dunner DL; Rothschild AJ; Pedersen R; Dorries KM; Ninan PT
    J Nerv Ment Dis; 2013 Apr; 201(4):266-73. PubMed ID: 23538970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
    Iovieno N; van Nieuwenhuizen A; Clain A; Baer L; Nierenberg AA
    Depress Anxiety; 2011 Feb; 28(2):137-44. PubMed ID: 21284066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.